The ICD-10 code for Alkaptonuria is E70.2. Alkaptonuria is a rare genetic disorder characterized by the body's inability to break down certain amino acids. This leads to the accumulation of a substance called homogentisic acid, which can cause dark urine, joint and connective tissue problems, and other symptoms. In the ICD-9 coding system, Alkaptonuria is represented by code 270.2. It is important to consult with a healthcare professional for accurate diagnosis and treatment.
Alkaptonuria is a rare, inherited metabolic disorder characterized by the inability of the body to properly break down certain amino acids, specifically phenylalanine and tyrosine. This results in the accumulation of a substance called homogentisic acid, leading to a variety of symptoms primarily affecting the musculoskeletal system and connective tissues.
In the International Classification of Diseases, 10th Revision (ICD-10), alkaptonuria is classified under E70.2. This specific code falls under the category of "Disorders of aromatic amino-acid metabolism." The ICD-10 code E70.2 is used to accurately identify and classify patients with alkaptonuria in medical records and billing systems.
In the previous edition, the 9th Revision (ICD-9), alkaptonuria was classified under 270.2. This ICD-9 code falls within the broader category of "Disorders of amino-acid transport and metabolism."
It is important to note that the transition from ICD-9 to ICD-10 occurred in most countries on October 1, 2015. Therefore, healthcare providers now primarily use the ICD-10 code E70.2 to document and identify cases of alkaptonuria. However, some older medical records or systems may still use the ICD-9 code 270.2.
Overall, alkaptonuria is a rare metabolic disorder, and its ICD-10 code is E70.2, while the corresponding ICD-9 code is 270.2. These codes assist healthcare professionals in accurately documenting and tracking patients with this condition for appropriate diagnosis, treatment, and research purposes.